In murine models of coronary heart disease, addition of EGCG activates the Nrf2/HO-1/NQO1 pathway restoring protein expression of Nrf2, HO-1, and NQO1, thereby reducing cardiac tissue damage [162]. The gene discussed is NFE2L2; the disease is coronary artery disorder.